Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Huang, Bingqing ^a   Qian, Juying ^a   Ma, Jianying ^a   Huang, Zheyong ^a   Shen, Yunli ^a   Chen, Xueying ^a   Sun, Aijun ^a   Ge, Junbo ^a   Chen, Haozhu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENGRAFTMENT; EXPERIMENTAL MYOCARDIAL INFARCTION; FEMALE; FRACTIONAL SHORTENING; GENE EXPRESSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TISSUE REPAIR; ANIMAL; CELL CULTURE; CYTOLOGY; GENE THERAPY; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY;

ANIMALIA; RATTUS;

ANIMALS; CELLS, CULTURED; FEMALE; GENETIC THERAPY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84896702815     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt410     Document Type: Article

References (58)

1. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Eur Heart J 2008 29 1807 1818 10.1093/eurheartj/ehn220 18523058
2. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW, J Am Coll Cardiol 2007 50 1761 1767 10.1016/j.jacc.2007.07.041 17964040 (Pubitemid 47600592)
3. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B, Arch Intern Med 2007 167 989 997 10.1001/archinte.167.10.989 17533201 (Pubitemid 46835786)
4. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Das R, Jahr H, van Osch GJ, Farrell E, Tissue Eng Part B Rev 2010 16 159 168 10.1089/ten.teb.2009.0296 19698058
5. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Shi RZ, Li QP, Biochem Biophys Res Commun 2008 376 247 250 10.1016/j.bbrc.2008.09.004 18789897
6. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL, Eur Heart J 2006 27 1114 1122 16510464
7. Combining angiogenic gene and stem cell therapies for myocardial infarction. Pons J, Huang Y, Takagawa J, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW, Su H, J Gene Med 2009 11 743 753 10.1002/jgm.1362 19554624
8. VEGF improves survival of mesenchymal stem cells in infarcted hearts. Pons J, Huang Y, Arakawa-Hoyt J, Washko D, Takagawa J, Ye J, Grossman W, Su H, Biochem Biophys Res Commun 2008 376 419 422 10.1016/j.bbrc.2008.09.003 18789891
9. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, Zhang L, Huang Y, Eur J Cardiothorac Surg 2009 36 644 650 10.1016/j.ejcts.2009.04.052 19524448
10. Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Zhao T, Zhang D, Millard RW, Ashraf M, Wang Y, Am J Physiol Heart Circ Physiol 2009 296 976 H986 10.1152/ajpheart.01134.2008 19181961
11. Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model. Shudo Y, Miyagawa S, Ohkura H, Fukushima S, Saito A, Shiozaki M, Kawaguchi N, Matsuura N, Shimizu TMP, Okano TPD, Matsuyama A, Sawa Y, Tissue Eng Part A 2014 20 728 739 24164292
12. Integrated platform for functional monitoring of biomimetic heart sheets derived from human pluripotent stem cells. Chen A, Lee E, Tu R, Santiago K, Grosberg A, Fowlkes C, Khine M, Biomaterials 2014 35 675 683 10.1016/j.biomaterials.2013.10.007 24144905
13. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Shao H, Tan Y, Eton D, Yang Z, Uberti MG, Li S, Schulick A, Yu H, Stem Cells 2008 26 1376 1384 10.1634/stemcells.2007-0785 18308946
14. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, Fischer R, Krieg L, Hirsch E, Huber B, Nathan P, Israel L, Imhof A, Herbach N, Assmann G, Wanke R, Mueller-Hoecker J, Steinbeck G, Franz WM, Cell Stem Cell 2009 4 313 323 10.1016/j.stem.2009.02.013 19341621
15. Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose. Templin C, Kotlarz D, Faulhaber J, Schnabel S, Grote K, Salguero G, Luchtefeld M, Hiller KH, Jakob P, Naim HY, Schieffer B, Hilfiker-Kleiner D, Landmesser U, Limbourg FP, Drexler H, J Mol Cell Cardiol 2008 45 394 403 10.1016/j.yjmcc.2008. 06.010 18671980
16. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA, N Engl J Med 2000 342 626 633 10.1056/NEJM200003023420904 10699162 (Pubitemid 30118415)
17. Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Shintani S, Kusano K, Ii M, Iwakura A, Heyd L, Curry C, Wecker A, Gavin M, Ma H, Kearney M, Silver M, Thorne T, Murohara T, Losordo DW, Nat Clin Pract Cardiovasc Med 2006 3 123 S128 16501618
18. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL, Mol Cell Biol 1996 16 4604 4613 8756616 (Pubitemid 26272112)
19. Angiogenesis in ischemic and neoplastic disorders. Semenza GL, Annu Rev Med 2003 54 17 28 10.1146/annurev.med.54.101601.152418 12359828 (Pubitemid 37386383)
20. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Jung F, Palmer LA, Zhou N, Johns RA, Circ Res 2000 86 319 325 10.1161/01.RES.86.3.319 10679484 (Pubitemid 30108826)
21. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL, Prchal JT, Nat Genet 2002 32 614 621 10.1038/ng1019 12415268 (Pubitemid 35435173)
22. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS, Mol Cell Biol 2003 23 359 369 10.1128/MCB.23.1.359-369.2003 12482987 (Pubitemid 36008526)
23. Adenovirus-mediated hypoxia-inducible factor 1alpha double-mutant promotes differentiation of bone marrow stem cells to cardiomyocytes. Wang Y, Feng C, Xue J, Sun A, Li J, Wu J, J Physiol Sci 2009 59 413 420 10.1007/s12576-009-0050-x 19603255
24. Increased expression of CXCR4 and integrin alphaM in hypoxia- preconditioned cells contributes to improved cell retention and angiogenic potency. Kubo M, Li TS, Kamota T, Ohshima M, Qin SL, Hamano K, J Cell Physiol 2009 220 508 514 10.1002/jcp.21803 19415696
25. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ, J Exp Med 2006 203 2201 2213 10.1084/jem.20052144 16940167 (Pubitemid 44352240)
26. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, Prockop DJ, PLoS One 2007 2 416 10.1371/journal.pone.0000416 17476338
27. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G, Circ Res 2009 104 1209 1216 10.1161/CIRCRESAHA.109.197723 19407239
28. Oxygen(es) and the hypoxia-inducible factor-1. Wenger RH, Gassmann M, Biol Chem 1997 378 609 616 9278140 (Pubitemid 27361853)
29. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA, J Am Coll Cardiol 2005 46 2116 2124 10.1016/j.jacc.2005.08.045 16325051 (Pubitemid 41713601)
30. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC, Nat Med 2004 10 858 864 10.1038/nm1075 15235597 (Pubitemid 39070860)
31. Post-ischemic administration of diazoxide attenuates long-term microglial activation in the rat brain after permanent carotid artery occlusion. Farkas E, Timmer NM, Domoki F, Mihaly A, Luiten PG, Bari F, Neurosci Lett 2005 387 168 172 10.1016/j.neulet.2005.06.036 16026930 (Pubitemid 41160550)
32. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair. Cerrada I, Ruiz-Sauri A, Carrero R, Trigueros C, Dorronsoro A, Sanchez-Puelles JM, Diez-Juan A, Montero JA, Sepulveda P, Stem Cells Dev 2013 22 501 511 10.1089/scd.2012.0340 22873764
33. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Shyu KG, Wang MT, Wang BW, Chang CC, Leu JG, Kuan P, Chang H, Cardiovasc Res 2002 54 576 583 10.1016/S0008-6363(02)00259-6 12031703 (Pubitemid 34595416)
34. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M, J Mol Cell Cardiol 2007 42 1036 1044 10.1016/j.yjmcc.2007.04.001 17498737 (Pubitemid 46829200)
35. In vivo optical imaging of cellular inflammatory response in granuloma formation using fluorescence-labeled macrophages. Eisenblatter M, Ehrchen J, Varga G, Sunderkotter C, Heindel W, Roth J, Bremer C, Wall A, J Nucl Med 2009 50 1676 1682 10.2967/jnumed.108.060707 19759121
36. Shan L, Near-Infrared Fluorescence 1,1-Dioctadecyl-3,3,3,3- Tetramethylindotricarbocyanine Iodide (Dir)-Labeled Macrophages for Cell Imaging Bethesda, MD: Molecular Imaging and Contrast Agent Database (MICAD) 2004
37. Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. Kalchenko V, Shivtiel S, Malina V, Lapid K, Haramati S, Lapidot T, Brill A, Harmelin A, J Biomed Opt 2006 11 050507 10.1117/1.2364903 17092148 (Pubitemid 44883884)
38. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Litwin SE, Katz SE, Morgan JP, Douglas PS, Circulation 1994 89 345 354 10.1161/01.CIR.89.1.345 8281668 (Pubitemid 24026509)
39. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Zhang C, Liu T, Su Y, Luo S, Zhu Y, Tan X, Fan S, Zhang L, Zhou Y, Cheng T, Shi C, Biomaterials 2010 31 6612 6617 10.1016/j.biomaterials.2010.05.007 20542559
40. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. Arminan A, Gandia C, Garcia-Verdugo JM, Lledo E, Trigueros C, Ruiz-Sauri A, Minana MD, Solves P, Paya R, Montero JA, Sepulveda P, J Am Coll Cardiol 2010 55 2244 2253 10.1016/j.jacc.2009.08.092 20466205
41. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA, Blood 2001 97 3354 3360 10.1182/blood.V97.11.3354 11369624
42. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W, Stem Cells 2004 22 405 414 10.1634/stemcells.22-3-405 15153617 (Pubitemid 38736624)
43. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ, Circulation 2004 110 3213 3220 10.1161/01.CIR.0000147609.39780. 02 15533859 (Pubitemid 39525068)
44. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Lopez JJ, Laham RJ, Carrozza JP, Tofukuji M, Sellke FW, Bunting S, Simons M, Am J Physiol 1997 273 1317 H1323 9321821
45. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Carmeliet P, Nat Med 2000 6 1102 1103 10.1038/80430 11017137
46. Bone marrow derived stromal cells modified by adenovirus-mediated HIF-1alpha double mutant protect cardiac myocytes against CoCl2-induced apoptosis. Wang Y, Sun A, Xue J, Feng C, Li J, Wu J, Toxicol In Vitro 2009 23 1069 1075 10.1016/j.tiv.2009.06.002 19520152
47. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508 (Pubitemid 40562318)
48. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Uemura R, Xu M, Ahmad N, Ashraf M, Circ Res 2006 98 1414 1421 10.1161/01.RES.0000225952.61196.39 16690882 (Pubitemid 43948066)
49. Paracrine mechanisms in adult stem cell signaling and therapy. Gnecchi M, Zhang Z, Ni A, Dzau VJ, Circ Res 2008 103 1204 1219 10.1161/CIRCRESAHA.108. 176826 19028920
50. Bone marrow cell therapy after myocardial infarction. What should we select? Landmesser U, Eur Heart J 2009 30 1310 1312 10.1093/eurheartj/ehp181 19429633
51. The mircrine mechanism controlling cardiac stem cell fate. Hosoda T, Front Genet 2013 4 204 24133503
52. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Won YW, McGinn AN, Lee M, Nam K, Bull DA, Kim SW, Biomaterials 2013 34 6229 6238 10.1016/j.biomaterials.2013.04.061 23714244
53. MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. Moon HH, Joo MK, Mok H, Lee M, Hwang KC, Kim SW, Jeong JH, Choi D, Kim SH, Biomaterials 2014 35 1744 1754 24280192
54. Transplantation of human mesenchymal stem cells loaded on collagen scaffolds for the treatment of traumatic brain injury in rats. Guan J, Zhu Z, Zhao RC, Xiao Z, Wu C, Han Q, Chen L, Tong W, Zhang J, Gao J, Feng M, Bao X, Dai J, Wang R, Biomaterials 2013 34 5937 5946 10.1016/j.biomaterials.2013.04.047 23664090
55. Crosslinked three-dimensional demineralized bone matrix for the adipose-derived stromal cell proliferation and differentiation. Zhao Y, Lin H, Zhang J, Chen B, Sun W, Wang X, Zhao W, Xiao Z, Dai J, Tissue Eng Part A 2009 15 13 21 10.1089/ten.tea.2008.0039 18652539
56. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Frith JE, Thomson B, Genever PG, Tissue Eng Part C Methods 2010 16 735 749 19811095
57. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. Emmert MY, Wolint P, Winklhofer S, Stolzmann P, Cesarovic N, Fleischmann T, Nguyen TD, Frauenfelder T, Boni R, Scherman J, Bettex D, Grunenfelder J, Schwartlander R, Vogel V, Gyongyosi M, Alkadhi H, Falk V, Hoerstrup SP, Biomaterials 2013 34 2428 2441 10.1016/j.biomaterials.2012.12. 021 23332174
58. Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Huang Z, Shen Y, Sun A, Huang G, Zhu H, Huang B, Xu J, Song Y, Pei N, Ma J, Yang X, Zou Y, Qian J, Ge J, Stem Cell Res Ther 2013 4 149 10.1186/scrt360 24330751